grepcent public filings, reorganized for comparison

CORVEL CORP (CRVL)

CIK: 0000874866. SIC: 6411 Insurance Agents, Brokers & Service. Latest 10-K as of: 2026-05-22.

SIC breadcrumb: Finance, Insurance, And Real Estate > SIC Major Group 64 > SIC 6411 Insurance Agents, Brokers & Service

SEC company page: https://www.sec.gov/edgar/browse/?CIK=874866. Latest filing source: 0001193125-26-237024.

Informational only. Descriptive public-record data — not a rating, forecast, or investment advice. See Disclaimer.

At a glance

FY2026 · period end 2026-03-31 · filed 2026-05-22 · accession 0001193125-26-237024 · source: SEC companyfacts

Revenue
958,527,000 USD verified
Net income
110,344,000 USD verified
Assets
642,986,000 USD verified
Free cash flow
110,283,000 USD computed
Net margin
11.51% computed
Revenue YoY
+7.03% computed
ROE
27.99% computed

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Revenue YoY = FY2026 revenue ÷ FY2025 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

Peer & cluster context

Peer percentile fingerprint

CRVL ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 6411; per-ratio N printed.CRVL ratios vs SIC peers. Source: grepcent computed from latest SEC companyfacts ratios; peer set SIC industry 6411; per-ratio N printed.RatioCRVLPeer medianPercentileNNet margin11.5%10.7%5715Revenue growth7.0%8.3%3615FCF margin11.5%14.0%3313ROE28.0%13.5%7915ROA17.2%3.8%10015Liabilities / equity0.632.362314Current ratio2.031.169213

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 6411 Insurance Agents, Brokers & Service, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue958,527,000USD20262026-05-22
Net income110,344,000USD20262026-05-22
Assets642,986,000USD20262026-05-22

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-05-22. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000874866.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2017201820192020202120222023202420252026
Revenue718,562,000795,311,000895,589,000958,527,000
Net income29,479,00035,695,00046,703,00047,377,00046,356,00066,410,00066,365,00076,252,00095,165,000110,344,000
Gross profit104,792,000107,253,000124,809,000125,921,000123,624,000152,114,000158,259,000171,693,000209,728,000232,863,000
Diluted EPS1.511.872.462.552.553.661.261.471.832.14
Operating cash flow52,052,00062,152,00078,639,00080,826,00094,379,00067,222,00082,288,00099,237,000127,315,000155,640,000
Capital expenditures31,041,00027,689,00015,274,00032,360,00017,243,00029,819,00026,320,00029,240,00035,755,00045,357,000
Share buybacks27,999,00011,187,00035,167,00065,608,00032,671,00090,085,00093,675,00045,710,00037,605,00056,206,000
Assets235,383,000274,004,000318,018,000416,260,000424,760,000415,246,000393,923,000454,679,000545,976,000642,986,000
Liabilities96,737,000102,828,000123,213,000226,549,000204,358,000202,851,000191,747,000207,032,000223,989,000248,755,000
Stockholders' equity138,646,000171,176,000194,805,000189,711,000220,402,000212,395,000202,176,000247,647,000321,987,000394,231,000
Cash and cash equivalents28,611,00055,771,00091,713,00083,223,000139,716,00097,504,00071,329,000105,563,000170,584,000233,072,000
Free cash flow21,011,00034,463,00063,365,00048,466,00077,136,00037,403,00055,968,00069,997,00091,560,000110,283,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2017201820192020202120222023202420252026
Net margin9.24%9.59%10.63%11.51%
Return on equity21.26%20.85%23.97%24.97%21.03%31.27%32.83%30.79%29.56%27.99%
Return on assets12.52%13.03%14.69%11.38%10.91%15.99%16.85%16.77%17.43%17.16%
Liabilities / equity0.700.600.631.190.930.960.950.840.700.63
Current ratio1.431.671.841.561.661.551.451.641.902.03

Industry Peer Context

Each number-line places CRVL against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

CRVL Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6411; peer count 15.CRVL Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6411; peer count 15.15 SIC peersMin -11.8%Median 10.7%Max 54.6%CRVL 11.5%

ROE peer context

CRVL ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6411; peer count 15.CRVL ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6411; peer count 15.15 SIC peersMin -5.6%Median 13.5%Max 81.8%CRVL 28.0%

ROA peer context

CRVL ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6411; peer count 15.CRVL ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 6411; peer count 15.15 SIC peersMin -0.9%Median 3.8%Max 17.2%CRVL 17.2%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Free cash flow = operating cash flow - capital expenditures

CRVL FY2026 free cash flow bridge from reported figures.CRVL FY2026 free cash flow bridge from reported figures.CRVL free cash flow bridgeFY2026: operating cash flow less capital expendituresSource: SEC companyfacts FY2026.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$155.6MOperating cash flow-$45.4MCapex$110.3MFree cash flow

Figure provenance: SEC companyfacts FY 2026. Operating cash flow: accession 0001193125-26-237024; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001193125-26-237024; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001193125-26-237024; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

CRVL revenue, last 4 periods. Source: SEC companyfacts FY2026.CRVL revenue, last 4 periods. Source: SEC companyfacts FY2026.CRVL RevenueLatest point: FY2026 = $958.5MSource: SEC companyfacts FY2026.Fiscal yearReported revenue$0.0B$500.0M$1.0B$718.6MFY2023$795.3MFY2024$895.6MFY2025$958.5MFY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: Revenues. Source concepts: us-gaap:Revenues.

CRVL net income, last 5 periods. Source: SEC companyfacts FY2026.CRVL net income, last 5 periods. Source: SEC companyfacts FY2026.CRVL Net incomeLatest point: FY2026 = $110.3MSource: SEC companyfacts FY2026.Fiscal yearNet income$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

CRVL gross profit, last 5 periods. Source: SEC companyfacts FY2026.CRVL gross profit, last 5 periods. Source: SEC companyfacts FY2026.CRVL Gross profitLatest point: FY2026 = $232.9MSource: SEC companyfacts FY2026.Fiscal yearGross profit$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.

CRVL diluted eps, last 5 periods. Source: SEC companyfacts FY2026.CRVL diluted eps, last 5 periods. Source: SEC companyfacts FY2026.CRVL Diluted EPSLatest point: FY2026 = $2.14/shareSource: SEC companyfacts FY2026.Fiscal yearDiluted EPS (USD/share)$0.00/share$3.00/share$6.00/shareFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

CRVL operating cash flow, last 5 periods. Source: SEC companyfacts FY2026.CRVL operating cash flow, last 5 periods. Source: SEC companyfacts FY2026.CRVL Operating cash flowLatest point: FY2026 = $155.6MSource: SEC companyfacts FY2026.Fiscal yearOperating cash flow$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

CRVL capital expenditures, last 5 periods. Source: SEC companyfacts FY2026.CRVL capital expenditures, last 5 periods. Source: SEC companyfacts FY2026.CRVL Capital expendituresLatest point: FY2026 = $45.4MSource: SEC companyfacts FY2026.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

CRVL share buybacks, last 5 periods. Source: SEC companyfacts FY2026.CRVL share buybacks, last 5 periods. Source: SEC companyfacts FY2026.CRVL Share buybacksLatest point: FY2026 = $56.2MSource: SEC companyfacts FY2026.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

CRVL assets, last 5 periods. Source: SEC companyfacts FY2026.CRVL assets, last 5 periods. Source: SEC companyfacts FY2026.CRVL AssetsLatest point: FY2026 = $643.0MSource: SEC companyfacts FY2026.Fiscal yearAssets$0.0B$375.0M$750.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: Assets. Source concepts: us-gaap:Assets.

CRVL liabilities, last 5 periods. Source: SEC companyfacts FY2026.CRVL liabilities, last 5 periods. Source: SEC companyfacts FY2026.CRVL LiabilitiesLatest point: FY2026 = $248.8MSource: SEC companyfacts FY2026.Fiscal yearLiabilities$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

CRVL stockholders' equity, last 5 periods. Source: SEC companyfacts FY2026.CRVL stockholders' equity, last 5 periods. Source: SEC companyfacts FY2026.CRVL Stockholders' equityLatest point: FY2026 = $394.2MSource: SEC companyfacts FY2026.Fiscal yearStockholders' equity$0.0B$250.0M$500.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

CRVL cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2026.CRVL cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2026.CRVL Cash and cash equivalentsLatest point: FY2026 = $233.1MSource: SEC companyfacts FY2026.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

CRVL free cash flow, last 5 periods. Source: SEC companyfacts FY2026.CRVL free cash flow, last 5 periods. Source: SEC companyfacts FY2026.CRVL Free cash flowLatest point: FY2026 = $110.3MSource: SEC companyfacts FY2026.Fiscal yearFree cash flow$0.0B$125.0M$250.0MFY2022FY2023FY2024FY2025FY2026

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-31; accession 0001193125-26-237024; filed 2026-05-22. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

As-reported value updates

No tracked differences above grepcent's stated thresholds and capped precision rule were found between the earliest XBRL-filed value and the value currently on file for the standardized annual metrics grepcent tracks.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-06. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0000874866.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q22022-09-30177,426,00014,656,0000.83reported discrete quarter
2022-Q32022-12-31179,386,00016,849,0000.96reported discrete quarter
2023-Q12023-06-30190,253,00019,805,0001.14reported discrete quarter
2023-Q22023-09-30195,522,00019,898,0001.15reported discrete quarter
2023-Q32023-12-31202,303,00017,095,0000.99reported discrete quarter
2024-Q12024-06-30211,722,00021,577,0001.25reported discrete quarter
2024-Q22024-09-30224,380,00023,398,0001.35reported discrete quarter
2024-Q32024-12-31227,973,00023,771,0000.46reported discrete quarter
2025-Q12025-06-30234,711,00027,235,0000.52reported discrete quarter
2025-Q22025-09-30239,643,00027,906,0000.54reported discrete quarter
2025-Q32025-12-31235,625,00024,174,0000.47reported discrete quarter
2026-Q12026-06-30259,925,00032,225,0000.63reported discrete quarter

Quarterly Charts

CRVL quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q1.CRVL quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q1.CRVL Quarterly RevenueLatest point: 2026-Q1 = $259.9MSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Revenue$0.0B$250.0M$500.0M2022-Q22022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-338216; filed 2026-08-06. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

CRVL quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q1.CRVL quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q1.CRVL Quarterly Net incomeLatest point: 2026-Q1 = $32.2MSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Net income$0.0B$125.0M$250.0M2022-Q22022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-338216; filed 2026-08-06. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

CRVL quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q1.CRVL quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q1.CRVL Quarterly Diluted EPSLatest point: 2026-Q1 = $0.63/shareSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Diluted EPS (USD/share)$0.00/share$1.00/share$2.00/share2022-Q22022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-06-30; accession 0001193125-26-338216; filed 2026-08-06. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Business

Read CRVL's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read CRVL's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Latest quarter (10-Q)

Latest 10-Q source: 0001193125-26-338216.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-08-06. Report date: 2026-06-30.

Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form 10-Q for our first fiscal quarter ended June 30, 2026 (this “Quarterly Report”) may include certain forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including (without limitation) statements with respect to anticipated future operating and financial performance, growth and acquisition opportunities and other similar forecasts and statements of expectation. Words such as “expects,” “anticipates,” “intends,” “plans,” “predicts,” “believes,” “seeks,” “estimates,” “potential,” “continue,” “strive,” “ongoing,” “may,” “will,” “would,” “could,” “should,” as well as variations of these words and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements made by the Company and its management are based on estimates, projections, beliefs and assumptions of management at the time of such statements and are not guarantees of future performance.

The Company disclaims any obligations to update or revise any forward-looking statement based on the occurrence of future events, the receipt of new information or otherwise. Actual future performance, outcomes, and results may differ materially from those expressed in forward-looking statements made by the Company and its management as a result of a number of risks, uncertainties and assumptions. Representative examples of these factors include (without limitation): general industry and economic conditions, including a decreasing number of national claims based on the number of injured workers; competition from other managed care companies and third party administrators; the Company’s ability to renew or maintain contracts with its customers on favorable terms or at all; the ability to expand certain areas of the Company’s business; growth in the Company’s sale of third-party administrator (“TPA”) services; shifts in customer demands; increases in operating expenses, including employee wages, benefits and medical inflation; the ability of the Company to produce market-competitive software; cost of capital and capital requirements; the Company’s ability to attract and retain key personnel; the impact of potential cybersecurity incidents on the Company’s business; existing and possible litigation and legal liability in the course of operations and the Company’s ability to resolve such litigation; changes in regulations affecting workers compensation, insurance and healthcare industries in general; governmental and public policy changes, including but not limited to legislative and administrative law and rule implementation or change; the impact of recently issued accounting standards on the Company’s consolidated financial statements; the availability of financing in the amounts, at the times, and on the terms necessary to support the Company’s future business; and the other risks identified in Part II, Item 1A of this Quarterly Report, under the heading “Risk Factors.”

Overview

The Company is an independent nationwide provider of medical cost containment and managed care services designed to address the escalating medical costs of workers’ compensation benefits, automobile insurance claims, and group health insurance benefits. The Company’s services are provided to insurance companies, TPAs, governmental entities, and self-administered employers to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. In January 2026, the Bureau of Labor Statistics reported that the occupational injury count for 2024 was 2.34 million compared to 2.37 million in 2023, 2.34 million in 2022, 2.24 million in 2021, 2.11 million in 2020, and 2.69 million in 2019. While the injury count has steadily increased since 2019, it has not returned to pre-pandemic levels. Despite fewer claims to administrate from 2020 to 2024 as compared to 2019, the Company has been able to overcome the decrease with an increase in market share.

Patient Management Services

The Company offers a range of patient management services, which involve working one-on-one with injured employees and their various healthcare professionals, employers and insurance company adjusters. Patient management services include claims management and all services sold to claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning. The services are designed to monitor the medical necessity and appropriateness of healthcare services provided to workers’ compensation and other healthcare claimants and to expedite return to work. The Company offers these services on a stand-alone basis, or as an integrated component of its medical cost containment services. Patient management services include the processing of claims for self-insured payors with respect to property and casualty insurance.

Network Solutions Services

The Company’s network solutions services are designed to reduce the price paid by its customers for medical services rendered in workers’ compensation cases, automobile insurance policies, and group health insurance policies. The network solutions services offered by the Company include automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. Network solutions services also include revenue from the Company’s directed care network (known as CareIQ), including imaging, physical therapy, durable medical equipment, translation and transportation.

Page 17

Organizational Structure

The Company’s management is structured geographically. Regional vice presidents are responsible for all services and the operating results within their respective regions, which may span multiple states. These regional vice presidents oversee area and district managers who hold similar responsibilities within their respective areas and districts.

Business Enterprise Segments

The Company operates in one reportable operating segment: managed care. It generates its revenue through its patient management and network solutions services. Both services are available to customers throughout the United States. Accordingly, the Company’s internal financial reporting is segmented geographically and managed on a geographic rather than service line basis, with virtually all of its operating revenue generated within the United States.

Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 280-10, “Segment Reporting,” establishes standards for the way that public business enterprises report information about operating segments in annual and interim consolidated financial statements. Under FASB ASC 280-10, two or more operating segments may be aggregated into a single operating segment for financial reporting purposes if aggregation is consistent with the objective and basic principles of the accounting guidance, if the segments have similar economic characteristics, and if the segments are similar in each of the following areas: (i) the nature of products and services, (ii) the nature of the production processes, (iii) the type or class of customer for their products and services, and (iv) the methods used to distribute their products or provide their services. The Company believes its patient management and network solutions services meet these criteria because they each provide similar managed care services and products to the same customer base using comparable methods of production and distribution and because each of our regions have similar economic characteristics.

Seasonality

While we are not directly impacted by seasonal shifts, we are affected by the change in working days in a given quarter. There are generally fewer working days for our employees to generate revenue in the third fiscal quarter due to employee vacations, inclement weather, and holidays.

Recent Developments

During the quarter ended September 30, 2025, the Company acquired a privately held technology firm adding proprietary tools and intellectual property for our enhanced bill review process.

Effective July 1, 2026, Michael G. Combs, the Chief Executive Officer, President, and Chairman of the Board of Directors (the “Board”) of the Company transitioned from his role as Chief Executive Officer and President of the Company and has been appointed by the Board to serve as Executive Chair, effective as of the same date. In connection with the leadership transition, the Board appointed Sarah A. Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.

Summary of Quarterly Results

The Company’s revenues increased to $259.9 million in the quarter ended June 30, 2026, from $234.7 million in the quarter ended June 30, 2025, an increase of $25.2 million, or 11%. This increase resulted primarily from an increase in network solutions and patient management activity with existing customers.

Cost of revenues increased to $192.1 million in the quarter ended June 30, 2026, from $178.0 million in the quarter ended June 30, 2025, an increase of $14.2 million, or 8%. This increase was primarily due to the increase of 11% in revenue mentioned above.

General and administrative expense increased to $24.5 million in the quarter ended June 30, 2026, from $21.5 million in the quarter ended June 30, 2025, an increase of $3.0 million, or 14%. General and administrative expense in the quarter ended June 30, 2026 consisted of approximately 11% of revenues. The Company expects the proportion of general and administrative expense in future quarters to be between 9% and 11% of revenues.

Income tax provision increased to $11.1 million in the quarter ended June 30, 2026, from $8.0 million in the quarter ended June 30, 2025, an increase of $3.1 million, or 38%. Income before income tax provision increased to $43.3 million in the quarter ended June 30, 2026, from $35.3 million in the quarter ended June 30, 2025, an increase of $8.1 million, or 23%. The effective tax rate was 26% for the quarter ended June 30, 2026, compared to 23% for the quarter ended June 30, 2025.

Page 18

Diluted weighted average common and common equivalent shares decreased to 50.9 million shares for the quarter ended June 30, 2026 from 51.9 million shares for the quarter ended June 30, 2025, a decrease of 984,000 shares, or 1.9%, due to the weighted impact of shares repurchased partially offset by the weighted impact of options exercised.

Diluted earnings per share increased to $0.63 per share in the quarter ended June 30, 2026, from $0.52 per share in the quarter ended June 30, 2025, an increase of $0.11 per share, or 21%. The increase in diluted earnings per share was primarily due to an increase in net income.

Results of Operations for the three months ended June 30, 2026 and 2025

The Company generates revenues from providing patient management and network solutions services to payors of workers’ compensation benefits, automobile insurance claims, and group health insurance benefits.

The following table sets forth, for the periods indicated, the dollar amounts, dollar and percent changes, share changes, and the percentage of revenues represented by certain items reflected in the Company’s unaudited consolidated income statements for the three months ended June 30, 2026 and 2025. The Company’s past operating results are not necessarily indicative of future operating results.

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: 0001193125-26-237024. The complete FY 2026 MD&A is published at /company/CRVL/mda/fy2026/.

Extracted from a later financial-section MD&A body after the formal Item 7 span was a short reference. Confidence: high. Filing date: 2026-05-22. Report date: 2026-03-31.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Management’s Discussion and Analysis of Financial Condition and Results of Operations may include certain forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, including without limitation statements with respect to anticipated future operating and financial performance, growth and acquisition opportunities and other similar forecasts and statements of expectation. Words such as “expects,” “anticipates,” “intends,” “plans,” “predicts,” “believes,” “seeks,” “estimates,” “potential,” “continue,” “strive,” “ongoing,” “may,” “will,” “would,” “could,” “should,” as well as variations of these words and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements made by the Company and its management are based on estimates, projections, beliefs and assumptions of management at the time of such statements and are not guarantees of future performance.

The Company disclaims any obligations to update or revise any forward-looking statement based on the occurrence of future events, the receipt of new information or otherwise. Actual future performance, outcomes, and results may differ materially from those expressed in forward-looking statements made by the Company and its management as a result of a number of risks, uncertainties and assumptions. Representative examples of these factors include without limitation; general industry and economic conditions, including a decreasing number of national claims due to a decreasing number of injured workers; competition from other managed care companies and third party administrators; the Company’s ability to renew or maintain contracts with its customers on favorable terms or at all; the ability to expand certain areas of the Company’s business; growth in the Company’s sale of TPA services; shifts in customer demands; increases in operating expenses, including employee wages, benefits, and medical inflation; the ability of the Company to produce market-competitive software; cost of capital and capital requirements; on the Company’s ability to attract and retain key personnel; the impact of potential cybersecurity incidents on the Company’s business; existing and possible litigation and legal liability in the course of operations and the Company’s ability to resolve such litigation; changes in regulations affecting the workers’ compensation, insurance and healthcare industries in general; governmental and public policy changes, including but not limited to legislative and administrative law and rule implementation or change; the impact of recently issued accounting standards on the Company’s consolidated financial statements; the availability of financing in the amounts, at the times, and on the terms necessary to support the Company’s future business, and the other risks identified in Part I, Item 1A of this Annual Report, “Risk Factors.”

Overview

The Company is an independent nationwide provider of medical cost containment and managed care services designed to address the escalating medical costs of workers’ compensation benefits, automobile insurance claims, and group health insurance benefits. The Company’s services are provided to insurance companies, TPAs, governmental entities, and self-administered employers to assist them in managing the medical costs of workers’ compensation, group health and auto insurance, and monitoring the quality of care provided to claimants.

Network Solutions Services

The Company’s network solutions services are designed to reduce the price paid by its customers for medical services rendered in workers’ compensation cases, automobile insurance policies, and group health insurance policies. The network solutions services offered by the Company include automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, Medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review. Network solutions services also include revenue from the Company’s directed care network (known as CareIQ), including imaging, physical therapy, durable medical equipment, and translation and transportation.

Patient Management Services

In addition to its network solutions services, the Company offers a range of patient management services, which involve working one-on-one with injured employees and their various healthcare professionals, employers and insurance company adjusters. Patient management services include claims management and all services sold to claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning. The services are designed to monitor the medical necessity and appropriateness of healthcare services provided to workers’ compensation and other healthcare claimants and to expedite return to work. The Company offers these services on a stand-alone basis, or as an integrated component of its medical cost containment services. Patient management services include the processing of claims for self-insured payors with respect to property and casualty insurance.

33

Segment Reporting

Based on the Company’s Chief Operating Decision Maker’s ("CODM") review and assessment of the Company’s operations for purposes of performance monitoring and resource allocation, the Company determined that its operations and the decisions to allocate resources and deploy capital are organized and managed on a consolidated basis. Accordingly, management has identified one operating segment, which is its reportable segment, under this organizational and reporting structure

Business Enterprise Segments

The Company operates in one reportable operating segment, managed care. The Company’s services are delivered to its customers through its local offices in each region and financial information for the Company’s operations follows this service delivery model. All regions provide the Company’s patient management and network solutions services to customers. Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) 280-10, “Segment Reporting” establishes standards for the way that public business enterprises report information about operating segments in annual and interim consolidated financial statements. The Company’s internal financial reporting is segmented geographically, as discussed above, and managed on a geographic rather than service line basis, with virtually all of the Company’s operating revenue generated within the United States.

Under FASB ASC 280-10, two or more operating segments may be aggregated into a single operating segment for financial reporting purposes if aggregation is consistent with the objective and basic principles, if the segments have similar economic characteristics, and if the segments are similar in each of the following areas: (i) the nature of products and services; (ii) the nature of the production processes; (iii) the type or class of customer for their products and services; and (iv) the methods used to distribute their products or provide their services. The Company believes each of its regions meet these criteria as each provides similar services and products to similar customers using similar methods of production and distribution.

Because we believe we meet each of the criteria set forth above and each of our regions have similar economic characteristics, we aggregate our results of operations in one reportable operating segment, managed care.

Number of Working Days

We are affected by the change in working days in a given quarter. There are generally fewer working days for our employees to generate revenue in the third fiscal quarter due to employee vacations, inclement weather and holidays.

Company Stock Split

During fiscal year 2025, the Company effected a three-for-one forward stock split of its common stock. All prior period share, equity award and per share amounts and calculations in this Annual Report and in the consolidated financial statements have been retroactively adjusted to reflect the stock split.

Summary of Fiscal 2026 Annual Results

The Company's revenues increased to $959 million in fiscal year 2026 from $896 million in fiscal year 2025, an increase of $63 million, or 7%. This increase was due to an increase in revenues primarily from network solutions activity with existing customers due to utilizing additional services with the Company.

During fiscal year 2026, the Company’s gross profit increased to $233 million from $210 million in fiscal year 2025, an increase of $23 million, or 11%. This increase was primarily due to the increase of 7% in revenue mentioned above, secondarily, a significant part of the growth was from the higher margin services of network solutions.

During fiscal year 2026, the Company’s general and administrative expenses increased to $89.7 million from $88.9 million in fiscal year 2025, an increase of $0.8 million, or 1%. Historically, general and administrative expenses have been between 9% and 10% of revenues.

During fiscal year 2026, the Company’s net income before tax increased to $143.1 million from $120.8 million in fiscal year 2025, an increase of $22.3 million, or 18%. The increase was primarily due to an increase in revenues and gross profit margin.

During fiscal year 2026, the Company’s income tax expense increased to $32.8 million from $25.7 million in fiscal year 2025, an increase of $7.1 million, or 28%. The increase was due to an increase in income before income taxes. The Company’s effective income tax rate was 23% for fiscal year 2026 and 21% for fiscal year 2025.

34

Diluted weighted average shares were 51.6 million shares in fiscal year 2026 and 52.0 million shares in fiscal year 2025, with a decrease of 369,000 shares, or 0.7%. This decrease was primarily due to the repurchase of 782,744 shares of common stock in fiscal year 2026 under the Company’s stock repurchase program. Since commencing this program in the fall of 1996, the Company has repurchased 115,259,435 shares of its common stock through March 31, 2026, at a cost of $888 million. These repurchases were funded primarily from the Company’s operating cash flows.

Diluted earnings per share increased to $2.14 per share in fiscal year 2026 from $1.83 per share in fiscal year 2025, an increase of $0.31 per share, or 17%. The increase in diluted earnings per share was primarily due to an increase in net income.

Results of Operations

The Company derives its revenues from providing patient management and network solutions services to payors of workers’ compensation benefits, automobile insurance claims, and group health insurance benefits. Patient management services include claims management and all services sold to claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning. Network solutions services include fee schedule auditing, hospital bill auditing, pharmacy, independent medical examinations, directed care services, diagnostic imaging review services and preferred provider referral services. The percentages of total revenues attributable to patient management and network solutions services for the fiscal years ended March 31, 2026, 2025 and 2024 are listed below.

202620252024
Patient management services62.3%64.9%66.6%
Network solutions services37.7%35.1%33.4%
100.0%100.0%100.0%

As noted in the table above, the percentage of

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2026 MD&A or browse all MD&A years.

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

Macro cross-references for CRVL

Indicators mapped to this company's SIC classification (industry 6411 Insurance Agents, Brokers & Service) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

Macro-to-micro threads including this sector: Money & trade, Government finances, Sector employment.

All 71 macro indicators →

For LLMs & downloads

Markdown twin: /company/CRVL.md · JSON record: /company/CRVL.json · verified financials: JSON / CSV · machine TOC for the whole site: /llms.txt